Developer docs
API playgroundTry for free, no card

Search company profiles

DCP Capital

Full company profile

uuid0000vvm

Namestring
DCP Capital
Legal namestring
DCP Holdings Limited
Websiteurl
dcpcapital.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

DCP Capital is a Hong Kong-domiciled (DCP Holdings Limited) international private equity firm founded in 2017 by veterans of KKR Asia and Morgan Stanley Private Equity Asia — co-founders David H. Liu (Executive Chairman, ex-co-head of KKR Asia PE and CEO of KKR Greater China) and Julian Juul Wolhardt (CEO, ex-Partner and Greater China Regional Leader at KKR). The firm invests control or significant-stake equity across Asia, with a portfolio spanning consumer, healthcare, manufacturing, agriculture, and financial services, including marquee transactions such as the $4.3 billion take-private of 51job (2022), the $1.7 billion acquisition of Alibaba's 79% stake in Sun Art Retail (2025), the carve-out of Sun Valley (formerly Cargill's China poultry business, 2023), and exclusive investments in Jamieson Wellness (consumer health JV) and American-Sino Healthcare (Shanghai premium obstetrics).

The firm operates a value-oriented, operationally focused investment model with a systematic post-investment management framework and a dedicated portfolio operations team. It does not offer technology products or platforms; instead, it generates revenue through management fees and carried interest on private equity funds raised from world-class long-term institutional investors including sovereign wealth funds, pension funds, endowments, family offices, and funds-of-funds. Deal sourcing is relationship-driven, leveraging three decades of partner-level networks to access proprietary opportunities from corporate sellers (Alibaba, Cargill) and founder-led businesses.

DCP maintains a lean team of 11–50 professionals across its Hong Kong headquarters and Beijing regional office (China World Tower A, Chaoyang District), and has built governance credentials including UN Principles for Responsible Investment signatory status (December 2021) and the 2025 AVCJ 'Operational Value Add Award'. Its stated differentiators are long-term capital, operational expertise across multiple sectors, and a partnership approach with management teams rather than purely financial engineering.

Short descriptiontext

DCP Capital is a Hong Kong-domiciled private equity firm founded in 2017 by ex-KKR and ex-Morgan Stanley Asia investors that deploys control and significant-stake capital into Asian consumer, healthcare, manufacturing, and financial services companies, serving institutional LPs through management fees and carried interest.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBeijing, China
HQ citystring
Beijing
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
private equity investments, Asia-focused investing, portfolio management services, consumer and healthcare investing, institutional capital management
Industry1 code
1Strategic / Balance-Sheet CVC (On-balance-sheet investing)
CodeFSANAHAAPrimaryYes
NAICS code1 code
  • Portfolio Management and Investment Advice523940
SIC code1 code
  • Investment Advice6282
Product category
Private Equity Investment Management
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Private Equity Fund Management
TypeManaged Services
Description

DCP Capital generates returns through management fees and carried interest from its private equity funds. The firm invests institutional capital from sovereign wealth funds, pension funds, endowments, family offices and funds of funds, and returns capital with gains through successful portfolio company exits.

dcpcapital.com
2Portfolio Company Investments
TypeTransaction Fee
Description

Returns generated through strategic investments in portfolio companies including Sun Art Retail ($1.7B acquisition), 51job ($4.3B take-private), and various healthcare, consumer, and technology companies, with exits generating carried interest.

platum.kr
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

DCP Capital is a private equity firm that manages institutional capital and makes controlling and significant minority investments in Asia-based companies with strong fundamentals, primarily in consumer, healthcare, manufacturing, agriculture, and financial services sectors. The firm partners with management teams and provides operational support through a dedicated portfolio operations team to accelerate growth, execute turnarounds, and enable exits that generate carried interest for its funds.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Successful turnaround and exit of Sun Valley in 2025 with strong returns for investors
+1 more record
Product overview1 text field

DCP Capital is a private equity firm that provides investment management services to institutional investors. The firm does not offer a technology product platform; instead, it offers investment vehicles and manages capital across various funds and portfolio companies in sectors including consumer, healthcare, manufacturing, agriculture, and financial services.

Product and service3 records
1Private Equity Fund Management Services
CategoryInvestment Management
2Portfolio Operations and Value Creation Services
CategoryAdvisory and Operational Services
3ESG Governance and Responsible Investment Services
CategoryResponsible Investment Governance
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global alternative asset manager with a deep Asia-Pacific buyout franchise. Carlyle pursues similar large take-private and strategic carve-out transactions in China consumer, healthcare, and industrial assets, directly overlapping with DCP's deal profile.

TypeDirect peer
Description

Large global private equity firm with an established Asia platform. CVC competes head-to-head with DCP in mid- to large-cap Asian buyouts and take-privates across consumer, financial services, and healthcare.

TypeDirect peer
Description

Global alternative asset manager with a large Asia private equity platform. DCP's founders (David Liu and Julian Wolhardt) previously co-led KKR Asia Private Equity, and the two firms share a sector focus on consumer, healthcare, and financial services in Asia, and have even co-invested (Adopt A Cow Dairy).

TypeDirect peer
Description

Global private equity firm with a long-standing Asia practice. Bain Capital competes with DCP for large-cap take-privates, control buyouts, and consumer/healthcare deals across Greater China and Southeast Asia.

TypeDirect peer
Description

Global private equity firm with a sizeable Asia practice covering China, India, and Southeast Asia. TPG pursues similar control-oriented buyouts in consumer, healthcare, and technology, and competes with DCP for the same Asian deal universe and LP relationships.

TypeDirect peer
Description

Global growth-oriented private equity firm with one of the longest-standing Asia franchises. Warburg Pincus competes for control and growth investments in Chinese consumer, healthcare, and financial services businesses with a similar long-hold philosophy.

TypeDirect peer
Description

Asia-focused alternative asset manager headquartered in Hong Kong with large private equity, credit, and hedge fund businesses. PAG is one of the closest direct competitors to DCP in Asia-focused control buyouts.

TypeDirect peer
Description

Asia-focused investment firm with a sizable private equity practice spanning consumer, healthcare, and business services in China. Hillhouse is a direct competitor for the same Chinese growth and buyout opportunities DCP pursues.

TypeRegional player
Description

China-focused private equity firm making large control investments across consumer, technology, healthcare, and financial services. Highly comparable deal-by-deal to DCP, but primarily focused on Greater China rather than pan-Asia.

TypeRegional player
Description

Asia-focused alternative asset manager with private equity, real estate, and special situations businesses. CITIC Capital competes with DCP for large Chinese buyouts and take-privates, leveraging deep domestic relationships and an extensive sector network.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment15 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

DCP Capital

Private Equity Investment Managementdcpcapital.com

DCP Capital is a Hong Kong-domiciled private equity firm founded in 2017 by ex-KKR and ex-Morgan Stanley Asia investors that deploys control and significant-stake capital into Asian consumer, healthcare, manufacturing, and financial services companies, serving institutional LPs through management fees and carried interest.

What DCP Capital does

DCP Capital is a Hong Kong-domiciled (DCP Holdings Limited) international private equity firm founded in 2017 by veterans of KKR Asia and Morgan Stanley Private Equity Asia — co-founders David H. Liu (Executive Chairman, ex-co-head of KKR Asia PE and CEO of KKR Greater China) and Julian Juul Wolhardt (CEO, ex-Partner and Greater China Regional Leader at KKR). The firm invests control or significant-stake equity across Asia, with a portfolio spanning consumer, healthcare, manufacturing, agriculture, and financial services, including marquee transactions such as the $4.3 billion take-private of 51job (2022), the $1.7 billion acquisition of Alibaba's 79% stake in Sun Art Retail (2025), the carve-out of Sun Valley (formerly Cargill's China poultry business, 2023), and exclusive investments in Jamieson Wellness (consumer health JV) and American-Sino Healthcare (Shanghai premium obstetrics).

The firm operates a value-oriented, operationally focused investment model with a systematic post-investment management framework and a dedicated portfolio operations team. It does not offer technology products or platforms; instead, it generates revenue through management fees and carried interest on private equity funds raised from world-class long-term institutional investors including sovereign wealth funds, pension funds, endowments, family offices, and funds-of-funds. Deal sourcing is relationship-driven, leveraging three decades of partner-level networks to access proprietary opportunities from corporate sellers (Alibaba, Cargill) and founder-led businesses.

DCP maintains a lean team of 11–50 professionals across its Hong Kong headquarters and Beijing regional office (China World Tower A, Chaoyang District), and has built governance credentials including UN Principles for Responsible Investment signatory status (December 2021) and the 2025 AVCJ 'Operational Value Add Award'. Its stated differentiators are long-term capital, operational expertise across multiple sectors, and a partnership approach with management teams rather than purely financial engineering.

DCP Capital firmographics

Firmographics
Name
DCP Capital
Legal name
DCP Holdings Limited
Website
https://dcpcapital.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
DCP Capital is a Hong Kong-domiciled private equity firm founded in 2017 by ex-KKR and ex-Morgan Stanley Asia investors that deploys control and significant-stake capital into Asian consumer, healthcare, manufacturing, and financial services companies, serving institutional LPs through management fees and carried interest.
Ownership category
akta.pro rank

DCP Capital industry classification

Industry
Product category
Private Equity Investment Management
NAICS
Portfolio Management and Investment Advice (523940)
SIC
Investment Advice (6282)
akta.pro primary industry
Strategic / Balance-Sheet CVC (On-balance-sheet investing) (FSANAHAA)

Keywords

  • Private equity investments
  • Asia-focused investing
  • Portfolio management services
  • Consumer and healthcare investing
  • Institutional capital management

Where DCP Capital is headquartered

Location

Headquarters

HQ city
Beijing
HQ country
China
HQ region
Asia

Offices2 records

Markets served

DCP Capital business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Private Equity Fund Management: DCP Capital generates returns through management fees and carried interest from its private equity funds. The firm invests institutional capital from sovereign wealth funds, pension funds, endowments, family offices and funds of funds, and returns capital with gains through successful portfolio company exits.
  2. Portfolio Company Investments: Returns generated through strategic investments in portfolio companies including Sun Art Retail ($1.7B acquisition), 51job ($4.3B take-private), and various healthcare, consumer, and technology companies, with exits generating carried interest.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

DCP Capital product offering

Product offering

Core offering

DCP Capital is a private equity firm that manages institutional capital and makes controlling and significant minority investments in Asia-based companies with strong fundamentals, primarily in consumer, healthcare, manufacturing, agriculture, and financial services sectors. The firm partners with management teams and provides operational support through a dedicated portfolio operations team to accelerate growth, execute turnarounds, and enable exits that generate carried interest for its funds.

Product overview

DCP Capital is a private equity firm that provides investment management services to institutional investors. The firm does not offer a technology product platform; instead, it offers investment vehicles and manages capital across various funds and portfolio companies in sectors including consumer, healthcare, manufacturing, agriculture, and financial services.

Differentiator

Problem solved

Functional benefit

Products and services

  • Private Equity Fund Management Services
  • Portfolio Operations and Value Creation Services
  • ESG Governance and Responsible Investment Services

Quantifiable outcome

  • Successful turnaround and exit of Sun Valley in 2025 with strong returns for investors
  • +1 more outcomes

Companies that use DCP Capital

Customer profile

Named customers8 records

Segments2 records

Ideal customer profiles2 records

DCP Capital technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

DCP Capital partnerships and signals

Strategic signal

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

DCP Capital competitors and assessment

Company assessment

Direct peers

  • The Carlyle Group: Global alternative asset manager with a deep Asia-Pacific buyout franchise. Carlyle pursues similar large take-private and strategic carve-out transactions in China consumer, healthcare, and industrial assets, directly overlapping with DCP's deal profile.
  • CVC Capital Partners: Large global private equity firm with an established Asia platform. CVC competes head-to-head with DCP in mid- to large-cap Asian buyouts and take-privates across consumer, financial services, and healthcare.
  • KKR & Co. Global alternative asset manager with a large Asia private equity platform. DCP's founders (David Liu and Julian Wolhardt) previously co-led KKR Asia Private Equity, and the two firms share a sector focus on consumer, healthcare, and financial services in Asia, and have even co-invested (Adopt A Cow Dairy).
  • Bain Capital: Global private equity firm with a long-standing Asia practice. Bain Capital competes with DCP for large-cap take-privates, control buyouts, and consumer/healthcare deals across Greater China and Southeast Asia.
  • TPG: Global private equity firm with a sizeable Asia practice covering China, India, and Southeast Asia. TPG pursues similar control-oriented buyouts in consumer, healthcare, and technology, and competes with DCP for the same Asian deal universe and LP relationships.
  • Warburg Pincus: Global growth-oriented private equity firm with one of the longest-standing Asia franchises. Warburg Pincus competes for control and growth investments in Chinese consumer, healthcare, and financial services businesses with a similar long-hold philosophy.
  • PAG (Pacific Alliance Group): Asia-focused alternative asset manager headquartered in Hong Kong with large private equity, credit, and hedge fund businesses. PAG is one of the closest direct competitors to DCP in Asia-focused control buyouts.
  • Hillhouse Capital: Asia-focused investment firm with a sizable private equity practice spanning consumer, healthcare, and business services in China. Hillhouse is a direct competitor for the same Chinese growth and buyout opportunities DCP pursues.

Regional players

  • Boyu Capital: China-focused private equity firm making large control investments across consumer, technology, healthcare, and financial services. Highly comparable deal-by-deal to DCP, but primarily focused on Greater China rather than pan-Asia.
  • CITIC Capital: Asia-focused alternative asset manager with private equity, real estate, and special situations businesses. CITIC Capital competes with DCP for large Chinese buyouts and take-privates, leveraging deep domestic relationships and an extensive sector network.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

DCP Capital social profiles

Digital presence

DCP Capital compliance and trust

Trust signal

Compliance1 record

DCP Capital financial estimates

Financial estimate

Revenue estimate

Valuation estimate

DCP Capital leadership team

Management profile

Number of profiles

Profiles4 records

DCP Capital funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

DCP Capital M&A and investment

M&A and investment

M&A3 records

Investments15 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DCP Capital

What does DCP Capital do?

DCP Capital is a private equity firm that manages institutional capital and makes controlling and significant minority investments in Asia-based companies with strong fundamentals, primarily in consumer, healthcare, manufacturing, agriculture, and financial services sectors. The firm partners with management teams and provides operational support through a dedicated portfolio operations team to accelerate growth, execute turnarounds, and enable exits that generate carried interest for its funds.

Is DCP Capital a public or private company?

DCP Capital is a private company. It is classified as management employee owned and is currently operating.

When was DCP Capital founded?

DCP Capital was founded in 2017. It employs 11 to 50 people.

Where is DCP Capital based?

DCP Capital is headquartered in Beijing, China, in the Asia region.

How does DCP Capital make money?

Two revenue lines are on record. Private Equity Fund Management is the primary driver. The others are portfolio Company Investments.

Who are DCP Capital's main competitors?

Direct peers on record are The Carlyle Group, CVC Capital Partners, KKR & Co., Bain Capital, TPG, Warburg Pincus, PAG (Pacific Alliance Group) and Hillhouse Capital. Regional players are Boyu Capital and CITIC Capital.

Does DCP Capital have an API?

No public API is recorded for DCP Capital.

What industry is DCP Capital in?

DCP Capital's product category is Private Equity Investment Management. Its primary akta.pro industry code is FSANAHAA, Strategic / Balance-Sheet CVC (On-balance-sheet investing). Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Platum[China Business Trends & Developments] Huawei, Miniso, and Xreal: How They Are Surviving in Their Own WaysAlibaba Group has completed the sale of its offline retail assets, selling its stake in Sun Art Retail Group to DCP Capital for USD 1.7 billion and Intime Retail to Youngor Fashion for USD 1 billion, collectively absorbing losses exceeding CNY 2.2 billion. The divestments mark the end of Alibaba's 'New Retail' strategy, which failed after three consecutive years of revenue decline at Sun Art, including a net loss of CNY 1.6 billion in fiscal year 2024. Under CEO Wu Yongming, Alibaba is redirecting resources toward AI infrastructure and planning to reduce its workforce by approximately 34% from 194,320 to 128,197 employees in 2025.Caixin GlobalSun Art Retail CEO Vanishes After Two Months on the JobSun Art Retail Group announced on February 4, 2026, that it has been unable to contact its CEO Li Weiping, who had held the position for approximately two months since her appointment in December 2025. The disappearance follows significant leadership upheaval triggered by Alibaba's sale of its 79% stake in Sun Art to DCP Capital for HK$13.1 billion ($1.7 billion) in early 2025, which led to a boardroom overhaul and replacement of executives with DCP Capital appointees. Sun Art, which operates the RT-Mart hypermarket chain, has been financially struggling, reporting a 1.6 billion yuan loss in fiscal 2024 before briefly turning profitable in fiscal 2025.Arc-GroupResurgence of PE-Backed Carve-Outs in ChinaPE-backed carve-out deals in China have rebounded strongly in 2025, reaching USD39bn in combined value and accounting for 8.8% of total M&A activity, driven by policy support for private capital, corporate deleveraging, multinational exit strategies, and SOE reforms. Notable transactions include Wanda Group's sale of 48 shopping malls to a PAG-led consortium for approximately USD7bn, Starbucks' sale of a 60% stake in its China business to Boyu Capital for USD2.4bn, and Alibaba's divestment of Sun Art Retail to DCP Capital for USD1.3bn. Industry executives anticipate continued momentum through 2026 as valuations reset, investor sentiment improves, and more multinationals and conglomerates seek to offload non-core assets to PE buyers capable of providing capital and operational expertise.BenzingaFrom Grocery Giant To Produce Pauper: Can Sun Art Turn The Aisle?Sun Art Retail Group Ltd. (6808.HK) warned it expects to report a net loss of 140 million yuan for the first half of fiscal year through September 2025, reversing a profit of 206 million yuan a year earlier, amid intensified price competition and weak consumer demand. Private equity firm DCP Capital, which acquired Sun Art from Alibaba in a deal worth HK$13.14 billion after Alibaba booked a loss of HK$37.1 billion on its investment, is implementing a sweeping turnaround including store closures, regional restructuring, and new superstore and M-club membership formats. The overhaul also includes management changes with the forced resignation of former chairman Huang Ming-Tuan and last month's removal of Chief Operating Officer Guan Mingwu by public security officials on suspicion of job-related crimes.The StandardAlibaba offers US$1.5b bid for grocery delivery platform Pupu: BloombergAlibaba plans to acquire grocery delivery platform Pupu for US$1.5 billion (HK$11.7 billion), more than doubling an earlier bid of US$600 million from Sun Art Retail, which is backed by DCP Capital. The acquisition signals Alibaba's intent to capture greater e-commerce market share from rival Meituan. Fujian-based Pupu generates annual revenue exceeding 30 billion yuan (HK$34.6 billion) and remains one of the few independent online grocery platforms in China yet to be acquired.The Times of IndiaAsian stocks: Asian shares kicks off New Year after ominous end to 2024 - The Economic TimesAsian and global equity markets faced headwinds entering 2025 after a turbulent end to 2024, with Shanghai futures declining and S&P 500 and Nasdaq dropping for a fourth consecutive session, erasing over a trillion dollars from large-cap market values. Key corporate developments included Nippon Steel's offer to grant the US government veto power over US Steel production capacity to secure approval for its takeover, Alibaba divesting its Sun Art Retail stake to DCP Capital, and BYD reaching 4.25 million passenger car sales for the year. Macroeconomically, China's central bank injected 1.7 trillion yuan to support markets, Singapore's economy expanded 4%, while Russian gas flows to Europe via Ukraine ceased after a five-decade transit deal expired.BenzingaAlibaba's Sun Art Faces Uncertainty as Trading Suspension Fuels Divestment Rumors: Report - Alibaba Gr HlSun Art Retail Group, the hypermarket operator majority-owned by Alibaba Group, saw its trading suspended, fueling speculation that Alibaba is preparing to divest its controlling stake. Bloomberg reported that Sun Art has received preliminary offers from private equity firms DCP Capital and Hillhouse Investment, following a 13.3% decline in annual revenue to 72.6 billion yuan ($10.3 billion) due to supply chain contraction and store closures. Alibaba acquired its controlling stake in Sun Art from France's Mulliez family in October 2020 for HK$28 billion ($3.6 billion).XueqiuCargill China sells its protein business to Dehong Capital, which has invested in Mengniu Dairy, COFCO Meat, and others (Fast-Moving Consumer Goods News). Recently, a spokesperson for Cargill, the world's largest agricultural commodity trader, confirmed that the company has agreed to sell its protein business in China to the private equity investment firm Dehong Capital (DCP)...Cargill has agreed to sell its protein business in China to private equity firm Dehong Capital (DCP), a transaction expected to be completed in 2023 pending regulatory approval. The deal involves approximately 3,000 employees and the transfer of Cargill's integrated broiler chicken base and other protein operations located in Chuzhou, Anhui.GlobeNewswireJamieson Wellness Inc. Closes Previously Announced Partnership with DCP CapitalJamieson Wellness closed a partnership with DCP Capital, which contributed $47.4 million in capital for a 33% stake in its Chinese operations. DCP also subscribed for $101.6 million in preferred shares and warrants. The company expects Chinese revenues of $47-50 million in fiscal 2023, a 65-75% annual growth rate.PE HubDCP Capital to buy stake in Chinese business of Jamieson WellnessDCP Capital has agreed to acquire a 33.3% minority stake in the Chinese business operations of Jamieson Wellness in exchange for approximately C$47.4 million. Additionally, DCP will subscribe for about C$101.6 million in preferred shares of Jamieson, with both transactions expected to close concurrently in the second quarter of 2023.